GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ABCG2, ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CDK6, CHRM1, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, F10, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, KDR, MAOA, MET, MIF, POLA1, POLB, PPARA, PTGS2, SLC1A1, SRC, TERT, TNKS, TNKS2, XDH |
12.2744 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, MMP2, MMP9, MPO, POLB, PPARA, PTGES, PTGS2, RELA, SRC, TYR |
12.0706 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, FABP3, FABP4, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MET, MIF, PPARA, PTGES, PTGS2, TBXAS1 |
11.2534 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
10.7614 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, IDO1, MPO, PTGES, PTGS2, RELA, SRC, TYR |
10.5814 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FUT7, GBA2, HMGCR, HSD17B3, IDO1, MIF, MPO, PIM1, PPARA, PTGES, PTGS2, TBXAS1, TYR, XDH |
10.3909 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, MMP2, MPO, POLB, PPARA, PTGES, PTGS2, RELA, SRC, TYR |
9.23157 |
[BP] GO:0042221 |
response to chemical
|
ABCG2, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, MMP2, MMP9, MPO, POLB, PPARA, PTGES, PTGS2, RELA, SRC, TERT, TOP1, TYR |
9.20375 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IDO1, MAOA, MPO, PTGS2, TBXAS1, TYR, XDH |
8.81212 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, GRM1, HCAR2, HMGCR, HTR6, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
8.81212 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, GRM1, HCAR2, HMGCR, HTR6, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
8.78763 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGES, PTGS2, TBXAS1 |
8.69157 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
8.4539 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGES, PTGS2, TBXAS1 |
8.39664 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, IDO1, IGF1R, KDR, MAP2K1, MIF, MMP12, MMP2, MMP9, PIM1, PTGES, PTGS2, RELA, SRC, TERT, XDH |
8.30089 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, HCAR2, HMGCR, IDO1, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, MPO, PIM1, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
7.63863 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F10, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
7.59493 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, HCAR2, HMGCR, IDO1, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, MPO, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
7.58393 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.48276 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F10, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
7.4776 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, HCAR2, HMGCR, IDO1, IGF1R, KDR, MAP2K1, MIF, MMP9, MPO, PIM1, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
7.13617 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, F10, F3, FLT3, GRM1, HMGCR, HTR6, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
7.08804 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
7.08258 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGES, PTGS2, TBXAS1 |
6.82861 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGES, PTGS2, TBXAS1 |
6.7341 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CYP1B1, F10, F3, FLT3, GRM1, HMGCR, HTR6, KDR, MAP2K1, MAP3K7, MET, MIF, PTGS2, PTPN1, RELA, SRC, XDH |
6.73201 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HSD11B2, PTGES, PTGS2, RELA, SRC, TYR |
6.67547 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESRRA, F10, F3, FABP4, FLT3, GRM1, HMGCR, HTR6, IDO1, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
6.63972 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
6.60758 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
6.49826 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CES2, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, MPO, PIM1, POLA1, POLB, PPARA, PTGES, PTGS2, PTPN1, RELA, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
6.40222 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PTGES, PTGS2, RELA, SRC, TERT |
6.33391 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AXL, BCL2, CACNA1C, CHRM1, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F10, F3, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, MPO, PIM1, PPARA, PTGS2, RELA, SRC, TNKS2, TOP1, TYR |
6.33391 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HTR6, IDO1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
6.32658 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IDO1, IGF1R, KDR, MET, MIF, MMP9, MPO, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC, TERT |
6.31025 |
[BP] GO:0050896 |
response to stimulus
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, MPO, POLA1, POLB, PPARA, PTGES, PTGS2, PTPN1, RELA, SRC, TERT, TOP1, TYR |
6.28496 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IDO1, IGF1R, KDR, MET, MIF, MMP9, MPO, PIM1, PTGS2, PTPN1, RELA, SRC, TERT |
6.27032 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, GBA2, HMGCR, MET, MIF, PPARA, PTGES, PTGS2, TBXAS1 |
6.24564 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CACNA1C, CDK6, CNR1, HCAR2, HMGCR, KDR, MIF, PTGS2, SRC, TNKS, TNKS2 |
6.24564 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CNR1, CYP1A1, HMGCR, MAP2K1, MIF, MPO, POLB, PTGS2, RELA, TERT |
6.21338 |
[BP] GO:0007187 |
None
|
ADORA1, CHRM1, CHRM2, CHRM4, CNR1, CNR2, GRM1, GRM3, GRM5, GRM8, HTR6 |
6.18734 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTGS2, RELA, TERT |
6.17411 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.15819 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, POLB, PPARA, RELA, SRC, TYR |
6.06027 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA, PTGES, PTGS2, TBXAS1 |
6.06027 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
5.98814 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
5.98814 |
[BP] GO:0042493 |
response to drug
|
ABCG2, AKR1B1, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, FABP3, HMGCR, HSD11B2, KDR, POLB, PTGS2, RELA, SRC, TOP1 |
5.98814 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.97688 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM4, GRM1, GRM3, GRM5, GRM8 |
5.91636 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IDO1, IGF1R, KDR, MIF, MMP9, MPO, PIM1, PTGS2, PTPN1, RELA, SRC, TERT |
5.7373 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HTR6, IDO1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RELA, SLC1A1, SRC, TERT, TNKS, TNKS2, XDH |
5.49605 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CES2, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, MPO, PIM1, POLA1, POLB, PPARA, PTGES, PTGS2, PTPN1, RELA, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
5.48231 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, PTGS2, RELA, SRC |
5.48231 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MPO, PTGES, PTGS2, RELA, SRC |
5.4657 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
5.4657 |
[BP] GO:0032787 |
None
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, IDO1, MIF, PPARA, PTGES, PTGS2, TBXAS1 |
5.44233 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CACNA1C, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP2, MMP9, PIM1, POLB, PPARA, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2 |
5.37684 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, GRM1, GRM3, GRM5, GRM8, PTGS2 |
5.37684 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, PIM1, PPARA, RELA, SRC |
5.37684 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALDH2, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, GBA2, HMGCR, HSD17B3, MAOA, TYR |
5.37618 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.25984 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, PPARA, PTGS2, RELA, SRC |
5.22761 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MPO, PTGES, PTGS2, RELA, SRC |
5.19079 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CDK6, CNR1, CNR2, CYP19A1, ESR1, F3, FABP4, HMGCR, IDO1, IGF1R, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
5.11369 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CDC25B, CDK6, CHRM1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, MET, MIF, MMP2, MMP9, MPO, PIM1, POLB, PPARA, PTGS2, RELA, SRC, TERT, TNKS2, TYR |
5.08881 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGES, PTGS2, TBXAS1 |
5.0816 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F10, F3, FLT3, GRM1, HMGCR, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, PTGS2, PTPN1, RELA, SRC, XDH |
5.08014 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CACNA1C, CDK6, CHRM1, CHRM2, CNR1, CYP1B1, ESR1, ESRRA, ESRRB, F3, GRM1, HCAR2, HMGCR, IDO1, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, PTGS2, RELA, SLC1A1, SRC, TERT, TNKS2, XDH |
5.0502 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.92706 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CA7, CACNA1C, CDK6, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1B1, F10, F3, GRIK5, GRM5, HCAR2, HMGCR, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT |
4.87752 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CDK6, CHRM1, CHRM4, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, MIF, MMP9, PTGS2, SRC, TERT |
4.82521 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.81621 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, ESRRB, F3, HCAR2, HMGCR, IDO1, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, PTGS2, RELA, SLC1A1, SRC, TERT |
4.75803 |
[BP] GO:0007188 |
None
|
ADORA1, CHRM1, CHRM2, CHRM4, CNR1, GRM1, GRM3, GRM5, GRM8 |
4.75803 |
[BP] GO:0071704 |
organic substance metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CES2, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, MPO, PIM1, POLA1, POLB, PPARA, PTGES, PTGS2, PTPN1, RELA, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
4.7325 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MIF, PTGES, PTGS2 |
4.7325 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, HMGCR, KDR, POLB, RELA, SRC |
4.7142 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CHRM1, CHRM4, CYP1A1, ESR1, FLT3, MAP2K1, MET, MIF, PIM1, POLA1, SRC, TYR |
4.56739 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADORA1, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, POLA1, POLB, SRC, TERT |
4.51203 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, ALDH2, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, GBA2, IDO1, MAOA, MMP1, MMP12, MMP2, MMP9, MPO, SRC, XDH |
4.49677 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP2, MMP9, POLA1, POLB, PTGS2, PTPN1, RELA, SRC, TERT |
4.42533 |
[BP] GO:0006082 |
organic acid metabolic process
|
ABCG2, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, IDO1, MIF, MPO, PIM1, PPARA, PTGES, PTGS2, TBXAS1, TYR |
4.3641 |
[BP] GO:0007154 |
None
|
ADORA1, AR, AXL, BCL2, CACNA1C, CHRM1, CHRM2, CHRM4, CNR1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR6, PTGS2, SLC1A1 |
4.35607 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM4, CNR1, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR6, SLC1A1 |
4.30948 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM4, CNR1, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR6, SLC1A1 |
4.30948 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CES2, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTGES, PTGS2, PTPN1, RELA, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
4.29915 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, F3, FABP4, HMGCR, IDO1, KDR, MAP2K1, MET, MIF, MMP12, PPARA, PTGS2, RELA |
4.29915 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, AR, BCL2, CDC25B, ESRRB, FLT3, GRM1, GRM5, HMGCR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
4.229 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CACNA1C, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, MIF, MMP9, PTGS2, SRC, TERT |
4.20541 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CHRM4, CSNK2A1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MAP3K7, MET, MIF, MMP2, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2 |
4.20541 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
4.18286 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
4.18286 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, GRM1, HMGCR, HSD11B2, MMP2, MPO, POLB, PPARA, PTGS2, RELA, SRC, TERT, TYR |
4.15279 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.11965 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2 |
4.10482 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GRM1, HMGCR, HTR6, IDO1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
4.09215 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.06313 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, MIF, MMP9, PTGS2, SRC, TERT |
4.04653 |
[BP] GO:0042391 |
None
|
ADORA1, APP, BCL2, CACNA1C, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.98603 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, PTGS2, RELA, SRC, TERT |
3.95385 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
3.90325 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, BCL2, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
3.90325 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, IDO1, MIF, MPO, PIM1, PPARA, PTGES, PTGS2, TBXAS1, TYR |
3.89298 |
[BP] GO:0009987 |
cellular process
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CDC25B, CDK6, CES2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD17B1, HSD17B2, HSD17B3, HTR6, IDO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, MPO, PIM1, POLA1, POLB, PPARA, PTGES, PTGS2, PTPN1, RELA, SLC1A1, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
3.8599 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
3.85389 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
3.85115 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, IDO1, MIF, PIM1, PPARA, PTGES, PTGS2, TBXAS1, TYR |
3.8316 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, MIF, MMP9, PTGS2, PTPN1, RELA, SRC, TERT |
3.82803 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM4 |
3.79114 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR, HSD17B3, IDO1 |
3.79025 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CACNA1C, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, MMP9, PIM1, POLB, PPARA, PTGS2, RELA, SRC, TYR |
3.77874 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, MIF, MMP9, PTGS2, SRC, TERT |
3.77646 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, MAP2K1, MAP3K7, MIF, MMP9, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
3.75155 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, HSD11B2, PTGS2, RELA, SRC |
3.71953 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, FLT3, GRM1, HMGCR, KDR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, XDH |
3.71953 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, HMGCR, HSD11B2, MPO, PTGS2, RELA, SRC, TYR |
3.69729 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, ALDH2, CYP1A2, CYP2A6, CYP3A4, MAOA, MPO |
3.68288 |
[BP] GO:0023052 |
None
|
ADORA1, AR, CACNA1C, CHRM1, CHRM2, CHRM4, CNR1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR6, SLC1A1 |
3.64447 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD17B3, IDO1, MIF, MPO, PTGES, PTGS2 |
3.63507 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, POLB, PPARA, PTGS2, SRC, TERT |
3.62838 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, PTGS2, RELA, SRC |
3.62629 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM4, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR6, SLC1A1 |
3.62252 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM4, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR6, SLC1A1 |
3.62252 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, IDO1, MAOA, MPO |
3.5879 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTGS2, TERT |
3.58258 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MMP12, MPO, PTGES, PTGS2, RELA, SRC |
3.55844 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM4 |
3.54314 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, HSD17B3, IDO1, MAP2K1, MMP2, MMP9, PTGS2, SRC |
3.51276 |
[BP] GO:0007267 |
None
|
ADORA1, AR, CHRM1, CHRM2, CHRM4, CNR1, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR6, SLC1A1 |
3.51276 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
3.5105 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, HMGCR, IDO1, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, MPO, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
3.5014 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, AR, BCL2, CDK6, CNR1, CNR2, CYP19A1, ESR1, ESR2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
3.46257 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS, TOP1 |
3.40003 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, BCL2, CDC25B, ESRRB, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
3.38229 |
[BP] GO:0065007 |
biological regulation
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR6, IDO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, MPO, PIM1, POLA1, POLB, PPARA, PTGES, PTGS2, PTPN1, RELA, SLC1A1, SRC, TERT, TNKS, TNKS2, TOP1, XDH |
3.37257 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.35713 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MMP12, MPO, PTGES, PTGS2, RELA, SRC |
3.35567 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.33662 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.33662 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, MMP9, PTGES, PTGS2, TERT |
3.32738 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CDK6, CYP1B1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, PTGS2, RELA, SRC |
3.29729 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, CNR1, CNR2, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, PTGS2, RELA, SRC, TYR |
3.25107 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ABCG2, ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, ESR1, F10, F3, FLT3, FUT7, GBA2, HMGCR, IDO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, POLB, PPARA, PTGS2, PTPN1, RELA, SRC, TNKS, TNKS2, TOP1, TYR, XDH |
3.23661 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CNR1, CYP1A1, HMGCR, HSD11B2, MPO, PTGS2, RELA, SRC, TYR |
3.23114 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.21393 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MPO |
3.21393 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
3.20978 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
3.13571 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
3.11378 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, GRM1, HMGCR, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.11178 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
3.10703 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, HMGCR, MIF, SRC, TNKS, TNKS2 |
3.10484 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, IDO1, MAP3K7, MMP12, MMP2, PPARA, PTGS2, PTPN1, RELA, SRC |
3.09927 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTGS2, PTPN1, SRC |
3.0982 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.0982 |
[BP] GO:0006693 |
None
|
CES2, MIF, PTGES, PTGS2 |
3.0982 |
[BP] GO:0006692 |
None
|
CES2, MIF, PTGES, PTGS2 |
3.0982 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, MMP9, MPO, PTGS2, RELA, SRC |
3.09722 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSD17B3, MAP2K1, SRC |
3.09722 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 |
3.09722 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, MAP2K1, PTGS2, SRC |
3.08172 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.08172 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AR, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, IGF1R, MAP2K1, MAP3K7, MET, MIF, MMP9, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, XDH |
3.07725 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, ESR2, F10, F3, FLT3, GRM1, HMGCR, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
3.07432 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GRM5, HSD11B2, IGF1R, PPARA, PTGS2, RELA, SRC |
3.0449 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, HCAR2, HMGCR, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
3.04035 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, ESR1, HMGCR, IGF1R, MET, MIF, MMP9, PTGS2, PTPN1, RELA, SRC, XDH |
3.03269 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, BCL2, CDK6, CYP1B1, FABP3, IDO1, MAP2K1, PTGES, PTGS2, TERT, XDH |
3.03269 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CACNA1C, CHRM1, CNR1, CYP19A1, GRIK5, GRM5, HCAR2, HMGCR, MAP2K1, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT |
3.03158 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1, HSD17B3 |
2.99422 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
2.9822 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, F3, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, MET, MIF, MMP9, PTPN1, RELA, SRC, TERT, TNKS, XDH |
2.97341 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, CSNK2A1, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTGS2, PTPN1, RELA, SRC, XDH |
2.96643 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, HCAR2, HMGCR, IDO1, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, MPO, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
2.95292 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.94658 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, AR, FLT3, GRM1, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, XDH |
2.94658 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, AR, BCL2, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.9462 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, CNR1, CNR2, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, PTGS2, RELA, SRC, TYR |
2.93572 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, PPARA, PTGS2, SRC |
2.9266 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
2.90223 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.90223 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
2.89658 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, TNKS, TNKS2, XDH |
2.89561 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ALPL, AXL, BCL2, CDK6, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, HMGCR, HSD11B2, IDO1, MMP12, MPO, PTGES, PTGS2, RELA, SRC, TYR |
2.86587 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, AR, BCL2, CNR2, ESR1, ESR2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
2.8548 |
[BP] GO:0048878 |
chemical homeostasis
|
ABCG2, AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, MET |
2.85101 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.85101 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, RELA, SRC |
2.85101 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
2.85101 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, AR, BCL2, CNR2, ESR1, ESR2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
2.84631 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, HCAR2, PTGS2, TNKS, TNKS2 |
2.83976 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.83976 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.7933 |
[BP] GO:0019371 |
None
|
PTGES, PTGS2, TBXAS1 |
2.7933 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.7767 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.73597 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
2.7324 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, IDO1, PPARA, PTGS2, RELA |
2.71777 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, POLB, PTGS2, PTPN1, SRC, TNKS, TOP1, XDH |
2.70419 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.70199 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
2.68806 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, AR, BCL2, CDC25B, FLT3, GRM1, GRM5, HMGCR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.68618 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
2.68152 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, F10, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.61278 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGES, PTGS2, RELA, SRC |
2.58876 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.58685 |
[BP] GO:0001516 |
None
|
MIF, PTGES, PTGS2 |
2.58685 |
[BP] GO:0046457 |
None
|
MIF, PTGES, PTGS2 |
2.58685 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX5, MIF, PTGES, PTGS2 |
2.5828 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
2.56065 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.5408 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR |
2.5397 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TNKS |
2.52323 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
2.51816 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
2.50936 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.50065 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTGS2, TERT |
2.48944 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
2.48463 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
2.48152 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, ESRRB, F3, HMGCR, IDO1, KDR, MAP2K1, PIM1, PTGS2, RELA, SRC, TERT |
2.46954 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, AR, BCL2, CACNA1C, CHRM1, CNR1, CSNK2A1, HCAR2, HMGCR, MIF, MMP12, PTGS2, PTPN1, SRC, TERT |
2.46925 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CNR1, CYP1B1, F3, GRIK5, HCAR2, HMGCR, IDO1, MMP9, PTGS2, SRC, XDH |
2.45313 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CACNA1C, CHRM1, CNR1, HCAR2, HMGCR, MIF, MMP12, PTGS2, PTPN1, SRC |
2.44969 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, BCL2, CA2, CA7, CACNA1C, CHRM1, CNR1, GRM5, MIF, MMP9, PTGS2 |
2.4492 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS, TOP1 |
2.43564 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CNR1, CYP1A1, HMGCR, PTGS2, RELA, TYR |
2.43564 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, FLT3, GRM1, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
2.42642 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.42455 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CNR1, CYP1B1, F3, GRIK5, HCAR2, HMGCR, IDO1, MMP9, PTGS2, SRC, XDH |
2.42375 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
2.42114 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, BCL2, CA2, CDK6, CNR1, CNR2, CYP19A1, ESR1, ESRRA, HCAR2, IDO1, MAP3K7, MIF, MMP12, MMP2, PTPN1, RELA, SRC |
2.4159 |
[BP] GO:2000106 |
regulation of leukocyte apoptotic process
|
AURKB, AXL, HCAR2, IDO1, MIF |
2.40967 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, MIF |
2.40967 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, PTGS2, RELA, TYR |
2.40967 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, AR, BCL2, CDC25B, ESR1, F3, FLT3, GRM1, GRM5, HMGCR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
2.40967 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.40899 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, ESR1, FLT3, PTGS2, SRC |
2.35575 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM4 |
2.35575 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.35575 |
[BP] GO:0070920 |
None
|
ESR1, MAP2K1, TERT |
2.35575 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, POLB, PTGS2, PTPN1, SRC, TNKS, TOP1, XDH |
2.31513 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.30866 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.30866 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.30866 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM4, ESR1, GRM5 |
2.30866 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, F3, FABP4, IDO1, KDR, MET, MIF, PTGS2 |
2.29582 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.29061 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
2.28855 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, KDR, SRC |
2.2738 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, KDR, PTGS2, RELA, SRC |
2.26875 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, HSD11B2, IDO1, MAP2K1, MAP3K7, MIF, MMP2, MMP9, MPO, POLA1, POLB, PPARA, PTGES, PTGS2, PTPN1, RELA, SRC, TERT |
2.25368 |
[BP] GO:2000107 |
negative regulation of leukocyte apoptotic process
|
AURKB, AXL, IDO1, MIF |
2.24493 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, CDK6, HMGCR, IGF1R, MAP2K1, MAP3K7, MET, MIF, PTGS2, PTPN1, TERT, XDH |
2.2316 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.22479 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, HMGCR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.19566 |
[BP] GO:0008217 |
None
|
ADORA1, AR, CNR1, HSD11B2, PPARA, PTGS2 |
2.19331 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, HMGCR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.18566 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CNR1, CYP1B1, F3, GRIK5, HCAR2, HMGCR, IDO1, MMP9, PTGS2, SRC, XDH |
2.16569 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.16194 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, F10, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, SRC, TNKS, TOP1 |
2.15636 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, BCL2, MIF, MMP9, PTGS2, PTPN1, RELA, SRC, TERT |
2.13054 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, PTGS2, SRC |
2.1092 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA |
2.09489 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, MAP3K7, PIM1, RELA |
2.07721 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, AR, BCL2, CDC25B, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTGS2, PTPN1, RELA, SRC, XDH |
2.07228 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTGS2, PTPN1, SRC |
2.07228 |
[BP] GO:0019233 |
None
|
CNR1, CNR2, GRM1, PTGS2 |
2.06984 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.06984 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.06082 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.06082 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.06082 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.06082 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.0589 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.0589 |
[BP] GO:0032094 |
None
|
CYP1A1, HSD11B2, MPO |
2.0589 |
[BP] GO:0051704 |
multi-organism process
|
APP, AXL, BCL2, CDK6, CHRM2, CYP1A1, HSD11B2, IDO1, KDR, MAP2K1, MET, MMP1, MMP12, MPO, POLA1, RELA, SRC, TOP1 |
2.0589 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, FLT3, GRM1, GRM5, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TNKS |
2.05764 |
[BP] GO:0050730 |
None
|
ADORA1, APP, FLT3, GRM5, MIF, PTPN1, SRC |
2.04517 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, MPO |
2.04346 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HMGCR, HSD17B3, TYR |
2.03803 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, RELA, SRC, TERT |
2.02586 |
[BP] GO:0090344 |
None
|
CDK6, MIF, TERT |
2.00867 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.00867 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.00867 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.00867 |
[CC] GO:0016020 |
membrane
|
ABCG2, ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, F10, F3, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HSD17B3, HTR6, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTGES, PTGS2, PTPN1, SLC1A1, SRC, TBXAS1, TERT, TNKS, TNKS2, TYR |
5.73065 |
[CC] GO:0098590 |
plasma membrane region
|
ABCG2, ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, PTGS2, SLC1A1, SRC |
4.87848 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, F10, FLT3, GBA2, GRIA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HSD17B3, PTGES, PTGS2, PTPN1, TBXAS1 |
4.86653 |
[CC] GO:0097060 |
None
|
CHRM1, CHRM2, CHRM4, CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.46218 |
[CC] GO:0005886 |
plasma membrane
|
ABCG2, ACHE, ADORA1, ADORA3, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, ESR1, F10, F3, FLT3, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTPN1, SLC1A1, SRC, TERT |
4.37076 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CACNA1C, CHRM1, CHRM2, CHRM4, CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
4.28167 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, GBA2, GRIA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HSD17B3, PTGES, PTGS2, TBXAS1 |
4.06132 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, CHRM1, CHRM2, CHRM4, CNR1, CNR2, F10, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR6, IGF1R, KDR, MET, SLC1A1 |
4.02815 |
[CC] GO:0042734 |
None
|
CNR1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.01666 |
[CC] GO:0044425 |
membrane part
|
ABCG2, ACHE, ADORA1, ADORA3, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, F10, F3, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HSD17B3, HTR6, IGF1R, KDR, MAOA, MET, PTGES, PTGS2, PTPN1, SLC1A1, SRC, TBXAS1, TYR |
3.95385 |
[CC] GO:0044444 |
cytoplasmic part
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, APP, AR, AURKB, BCL2, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CDK6, CES2, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IDO1, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP2, MMP9, MPO, PIM1, POLA1, PTGES, PTGS2, PTPN1, RELA, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
3.65054 |
[CC] GO:0044459 |
plasma membrane part
|
ABCG2, ADORA1, ADORA3, APP, AXL, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM4, CNR1, CNR2, F10, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR6, IGF1R, KDR, MET, PTGS2, SLC1A1, SRC |
3.38229 |
[CC] GO:0014069 |
None
|
ADORA1, CACNA1C, CHRM1, GRIK5, GRM1, GRM3, GRM5, SRC |
3.15947 |
[CC] GO:0099572 |
None
|
ADORA1, CACNA1C, CHRM1, GRIK5, GRM1, GRM3, GRM5, SRC |
3.15947 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.15802 |
[CC] GO:0043005 |
None
|
ADORA1, APP, CA2, CHRM1, CHRM2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, SRC |
3.0801 |
[CC] GO:0005783 |
None
|
ADORA1, APP, BCL2, CA4, CES2, CYP19A1, FLT3, GBA2, GRIK5, HMGCR, HSD17B3, KDR, MAP2K1, PTGS2, PTPN1, XDH |
2.86156 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR6, IGF1R, KDR, MET, SLC1A1 |
2.85101 |
[CC] GO:0097458 |
None
|
ADORA1, APP, CA2, CACNA1C, CHRM1, CHRM2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IDO1, PTGS2, SRC, TOP1 |
2.42375 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, APP, CA2, CDK6, CHRM1, CHRM2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR6, PTGS2, SRC |
2.30866 |
[CC] GO:0043226 |
organelle
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CA9, CACNA1C, CDK6, CES2, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HMGCR, HSD17B3, HTR6, IDO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, MPO, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, RELA, SHBG, SLC1A1, SRC, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.30494 |
[CC] GO:0045211 |
None
|
CHRM1, CHRM2, CHRM4, GRIA2, GRIA4, GRIK5, GRM3 |
2.24011 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.09919 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, APP, CA2, CDK6, CHRM1, CHRM2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR6, PTGS2, SRC |
2.0589 |
[CC] GO:0044464 |
cell part
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CDC25B, CDK6, CES2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR6, IDO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, MPO, PIM1, POLA1, POLB, PPARA, PTGES, PTGS2, PTPN1, RELA, SLC1A1, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.04809 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TYR, XDH |
12.2744 |
[MF] GO:0003824 |
catalytic activity
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CES2, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, F10, F3, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, MPO, PIM1, POLA1, POLB, PTGES, PTGS2, PTPN1, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
11.2534 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALDH2, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IDO1, MAOA, MPO, PTGS2, TBXAS1, TYR, XDH |
10.5304 |
[MF] GO:0048037 |
cofactor binding
|
ALDH2, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HMGCR, HSD11B2, HSD17B1, IDO1, MPO, POLA1, PTGES, PTGS2, SRC, TBXAS1, XDH |
9.29836 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.20375 |
[MF] GO:0043167 |
ion binding
|
ABCG2, ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IDO1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, MPO, PIM1, POLA1, POLB, PPARA, PTGES, PTGS2, PTPN1, RELA, SLC1A1, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
9.02027 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, IDO1, MPO, PTGS2, SRC, TBXAS1 |
8.69866 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, IDO1, MPO, PTGS2, SRC, TBXAS1 |
8.39408 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
7.53092 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.4481 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR6, IGF1R, KDR, MET, PPARA |
7.32414 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, SHBG |
6.63972 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TBXAS1, XDH |
6.63972 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, PPARA |
6.63132 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, CDK6, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR6, IGF1R, KDR, MET, PPARA |
6.63132 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TBXAS1, TYR |
6.33391 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR6, IGF1R, KDR, MET, PPARA |
6.32658 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
6.3025 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, XDH |
6.25009 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
5.95381 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM4, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HTR6 |
5.95381 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, PTGS2, TBXAS1, TYR |
5.80642 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, IDO1, MAP3K7, MMP1, MMP12, MMP2, MMP9, MPO, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, SLC1A1, TBXAS1, TERT, TNKS, TNKS2, TYR, XDH |
5.80367 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, IDO1, MAP3K7, MMP1, MMP12, MMP2, MMP9, MPO, PIM1, POLA1, POLB, PPARA, PTGS2, PTPN1, SLC1A1, TBXAS1, TERT, TNKS, TNKS2, TYR, XDH |
5.59553 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.54767 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, TNKS |
4.7325 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
4.7325 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.56326 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.53106 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.53106 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR6, IGF1R, KDR, MET |
4.51203 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, CNR1, CNR2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR6, IGF1R, KDR, MET |
4.51203 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.42842 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.29614 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.12138 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 |
3.98943 |
[MF] GO:0008144 |
drug binding
|
ABCG2, ACHE, AURKB, AXL, CDK6, CHRM1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PPARA, SRC, TOP1 |
3.95385 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.81195 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM4 |
3.79114 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, SHBG |
3.79025 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, ALDH2, AOX1, XDH |
3.51276 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
3.36353 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.03158 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, AOX1, APP, BCL2, CSNK2A1, ESR1, ESR2, FLT3, GRIK5, HMGCR, IGF1R, KDR, MAP3K7, MET, MIF, MMP9, PTGS2, RELA, TERT, TYR, XDH |
2.9462 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.89785 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
2.75852 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.70199 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.70199 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.70199 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
2.5828 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM4, HTR6 |
2.5408 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, POLA1, POLB, SRC, TERT, TOP1 |
2.54072 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.46609 |
[MF] GO:0019899 |
enzyme binding
|
APP, AR, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP3A4, ESR1, ESR2, ESRRB, F3, GRM5, HMGCR, MET, MIF, POLA1, POLB, PPARA, PTGS2, PTPN1, RELA, SRC, TNKS2 |
2.39661 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, SHBG |
2.34475 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.30866 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.30866 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.30866 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM4 |
2.22479 |
[MF] GO:0003674 |
molecular_function
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALDH2, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CDC25B, CDK6, CES2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR6, IDO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, MPO, PIM1, POLA1, POLB, PPARA, PTGES, PTGS2, PTPN1, RELA, SHBG, SLC1A1, SRC, TBXAS1, TERT, TNKS, TNKS2, TOP1, TYR, XDH |
2.21339 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.16194 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.16194 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.09919 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
2.07638 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.06082 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.06082 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.06082 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.06082 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.06082 |